Cyclovirobuxine D
CAS : 860-79-7
Ref. 3D-FC66624
25mg | 136,00 € | ||
50mg | 147,00 € | ||
100mg | 205,00 € | ||
250mg | 366,00 € | ||
500mg | 502,00 € |
Informations sur le produit
- (3beta,5alpha,9beta,16alpha,20S)-4,4,14-trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol
- (3beta,5alpha,9xi,10xi,14xi,16alpha,20S)-4,4,14-trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol
- (3α,5α,16α,20S)-4,4,14-Trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol
- (3β,5α,16α,20S)-4,4,14-Trimethyl-3,20-bis(methylamino)-9,19-cyclopregnan-16-ol
- 1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, 9,19-cyclopregnan-16-ol deriv.
- 9,19-Cyclo-5α,9β-pregnan-16α-ol, 4,4,14-trimethyl-3β,20α-bis(methylamino)-
- 9,19-Cyclopregnan-16-ol, 4,4,14-trimethyl-3,20-bis(methylamino)-, (3β,5α,16α,20S)-
- Bebuxine
- Cvb-D
- Cyclovirobuxin D
- Voir d'autres synonymes
- Cyclovirobuxine
- Cyclovirobuxinum D
- NSC 91722
Cyclovirobuxine D is a natural product that has been isolated from the stem bark of a Malaysian tree. It has shown synergistic effects with other compounds, such as cyclovirobuxine, in enhancing axonal growth and energy metabolism. Cyclovirobuxine D has also been shown to have a synergistic effect with cyclase inhibitors, such as rolipram and rolofylline, in the prevention of myocardial infarct. It blocks the cytosolic Ca2+ channel by binding to the ryanodine receptor and inhibiting Ca2+ release. The drug also inhibits glucose uptake in epithelial cells, which leads to cell death by apoptosis. Cyclovirobuxine D can be detected using analytical methods such as high-performance liquid chromatography (HPLC) or preparative HPLC.
Propriétés chimiques
Question d’ordre technique sur : 3D-FC66624 Cyclovirobuxine D
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages